Education
About Us
Working with TipRanks
Follow Us
Pulmonx (LUNG)
NASDAQ:LUNG
| Dec 24 | Dec 23 | Dec 22 | Dec 21 | Dec 20 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | $ 83.79M | $ 68.67M | $ 53.66M | $ 48.42M | $ 32.73M |
| Gross Profit | $ 62.00M | $ 50.75M | $ 39.87M | $ 35.63M | $ 21.20M |
| Operating Income | $ -57.70M | $ -61.94M | $ -58.64M | $ -47.30M | $ -32.33M |
| EBITDA | $ -50.79M | $ -55.09M | $ -55.99M | $ -46.62M | $ -28.44M |
| Net Income | $ -56.39M | $ -60.84M | $ -58.92M | $ -48.66M | $ -32.23M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | $ 101.48M | $ 117.10M | $ 141.14M | $ 180.04M | $ 231.79M |
| Total Assets | $ 162.85M | $ 177.78M | $ 193.68M | $ 235.17M | $ 263.71M |
| Total Debt | $ 56.47M | $ 41.42M | $ 24.40M | $ 26.46M | $ 27.22M |
| Net Debt | $ -14.43M | $ -42.12M | $ -77.33M | $ -122.02M | $ -204.57M |
| Total Liabilities | $ 77.04M | $ 59.47M | $ 39.67M | $ 41.93M | $ 37.57M |
| Stockholders' Equity | $ 85.81M | $ 118.31M | $ 154.01M | $ 193.24M | $ 226.13M |
| Cash Flow | |||||
| Free Cash Flow | $ -32.98M | $ -38.42M | $ -46.45M | $ -45.10M | $ -31.54M |
| Operating Cash Flow | $ -31.54M | $ -37.61M | $ -45.14M | $ -41.43M | $ -30.63M |
| Investing Cash Flow | $ 17.48M | $ -2.01M | $ -4.22M | $ -46.26M | $ 12.69M |
| Financing Cash Flow | $ 1.36M | $ 21.40M | $ 2.47M | $ 4.50M | $ 234.83M |